RH Capital

Congratulations to our newest portfolio company, Gesynta Pharma AB, which develops novel anti-inflammatory, pain-relieving pharmaceuticals, for securing $27M in a Series B financing round to continue developing a novel non-hormonal drug candidate for the treatment of endometriosis. Learn more ?? https://lnkd.in/dzYhfP-z #WomensHealth #Pharma #Gynecology #VentureCapital

Congratulations to maternity care provider?Millie?for securing $12M in Series A funding to expand its hybrid care model! Learn more ?? https://lnkd.in/ey8xUDwt #WomensHealth #MaternalHealth #VentureCapital

What happens when empathy is the cornerstone of your business model to deliver healthier maternal outcomes? Cayaba Care is creating a new standard for comprehensive maternal health care support throughout pregnancy, birth, and postpartum that leverages community-based care. Congratulations to CEO Adaeze Enekwechi and team for such a well-deserved highlight in Forbes, authored by Lisa K. Fitzpatrick MD, MPH, MPA. ????

Recent findings on vaginal dysbiosis may lead to improved prevention of cervical cancer among Native women. ?? “The study is unique in that we are doing it through the lens of Indigenous people and researchers,” said researcher Naomi Lee, PhD. Vaginal dysbiosis is a disruption in the balance of bacteria that increases the risk of human papillomavirus (HPV) infection, which can cause cervical cancer. The vaginal microbiome can dictate whether someone clears HPV or becomes infected and then at higher risk for developing cancer. Researchers found that protective microorganisms, which keep the vaginal microbiome healthy by guarding against pathogens, were dominant in 58% of non-Native women compared with 44% of Native women. Native women also had higher rates of vaginal dysbiosis and were more frequently infected with high-risk HPV. Researchers also spotlighted a connection between health disparities attributed to sociodemographic factors and a person’s healthy defense mechanisms. The hope is that these findings may ultimately lead to an intervention to modulate the microbiome in women with HPV and prevent the progression to cervical cancer. This potential intervention, along with existing vaccination recommendations, could lead to new prevention strategies. ?? Our portfolio company Evvy developed an at-home vaginal microbiome test, which is the first and only CLIA, CAP, and CLEP certified test that screens for all bacteria and fungi in the vaginal and urinary microbiome. Evvy’s website offers educational resources about the vaginal microbiome and vaginal health. ?? https://lnkd.in/eWvF42PZ #HealthEquity #WomensHealth #SexualHealth #Oncology #NativeWomen #IndianCountry

Congratulations to Eli Health whose Hormometer won Best of Innovation in the CES Innovation Awards 2025 program for Digital Health. Eli Health developed an at-home hormone testing system that uses a smartphone app to measure hormone levels in saliva. Eli's technology provides personalized hormone profiles to transform how women manage their hormonal health in areas like menopause, fertility, contraception, and endocrine conditions. When designed and deployed with intention, remote monitoring health technologies can promote health equity by giving individuals the ability to monitor vital signs from home, thereby providing more frequent monitoring and early intervention opportunities for chronic and acute conditions. This is especially relevant for individuals and communities in health care deserts, rural areas, and areas with health care facility or workforce shortages. ?? Learn more: https://lnkd.in/e8Cwj5QH #HealthEquity #ReproductiveHeath #WomensHealth #ObGyn #HealthTech #DigitalHealth

Congratulations to Bruno Van Tuykom and the team at Twentyeight Health upon announcing their $10M Series A funding and new partnerships with leading Medicaid insurers. Participating in the Medicaid market is a powerful strategy to advance health equity, expand coverage, and improve health outcomes for the millions of women covered by Medicaid today. The company offers comprehensive family planning, maternity, and sexual health resources including access to multiple birth control options, abortion pills, emergency contraception, and pregnancy tests as well as condoms, menstrual products and prenatal vitamins. 2 in 5 Twentyeight Health users do not see a primary care provider outside of the platform and nearly 3 in 5 identify as people of color. Before joining Twentyeight Health, 65% of users did not have access to birth control. ?? https://lnkd.in/e38sfaRh #HealthEquity #WomensHealth #ReproductiveHealth #MaternalHealth #BirthControl #Medicaid

Private and government investment will be critical to realizing the full potential of the women’s health market. Thrilled to see Anu Sharma of Millie highlighted for her insights on the future of women’s health investment – and as one more example of how transformative innovation can result when underrepresented founders start companies to solve the health care failures they experience. ?? https://lnkd.in/eSxYAb3s #WomensHealth #MaternalHealth #ReproductiveHealth #VentureCapital #ImpactInvesting

?? All of us at RH Capital wish you a joyful and healthy holiday season! ???? Our offices will be closed December 23, 2024 – January 2, 2025. There will be a delay in our reply if you contact us during that time. ?? We acknowledge the holidays can be difficult, emotionally and mentally. If you need support, or are concerned about someone you care about, the 988 Lifeline can help. It’s free, confidential, and available 24/7 by text, call, and chat. https://988lifeline.org/

?? 94% of workers described family benefits as “important” or “extremely important” in a survey by our friends at Ovia Health. Over 70% of workers said they’d switch companies for better family benefits. Employers are particularly?falling behind in three trending areas: reproductive and maternal health, paid leave, and menopause support. ? We're so pleased to see Rhia Ventures #WhatAreYourReproBenefits database and the Reproductive & Maternal Health Compass (RMH Compass) highlighted in Forbes as essential resources for companies invest in work-family benefits and remain competitive in 2025 ? ?? https://lnkd.in/gfxbGzny #HealthEquity #VentureCapital #HumanCapital #ImpactInvesting #HumanResources

?? A survey conducted by our portfolio company Cadence OTC found widespread confusion about the legality of emergency contraception. Only 40 percent of participants knew that emergency contraception in the form of the morning-after pill is legal in all 50 states.? “It’s primarily a result of some people conflating the morning-after pill with the abortion pill, believing that the morning-after pill will end an early pregnancy and therefore is illegal in states with abortion bans,” Cadence OTC co-Founder Samantha Miller ?? wrote to The Hill. For years, health advocates and clinicians have voiced the need for promoting greater public awareness and education about emergency contraception, and the current status of reproductive and maternal health in the US heightens this urgency exponentially. ?? https://lnkd.in/gfSYxqd4 #HealthEquity #WomensHealth #ReproductiveHealth #VentureCapital #ImpactInvesting